Opal et al. 1998. Clinical Infectious Diseases. , vol. 27: pp. 1497-1507. Intereleukin-10: potential benefits and possible Risks in Clinical infectious diseases.* |
Kalden et al. 1997. Current Opinion in Rheumatlogy. vol. 9: pp. 206-212. Biologic agents in the treament of inflammatory rheumatic diseases.* |
van Roon et al. Arthritis rheum 1996, May 36(5):829-35. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4.* |
Isomaki p et al. Arthritis rhem 1996, Mar 39(3):386-95. Interleukin-10 functions as an antiinflammtory cytokine in rheumatois synovium.* |
Tremaine, W.J., “The Medical Treatment of Active Crohn's Disease”, Drugs of Today 35 (Suppl. A):89-96 (1999). |
Durez, P. et al., “Methotrexate inhibits LPS-induced tumor necrosis factor production in vivo”, Eur. Cytokine Netw., 9:669 (Dec. 1998). |
Lacki, J. et al., “Circulating interleukin 10 and interleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts: Preliminary report”, Inflamm. Res 44:24 (1995). |
Asadullah, K. et al., “IL-10 Is aKey Cytokine in Psoriasis. Proof of Principle by IL-10 Therapy: A New Therapeutic Approach”, J. Clin. Invest, 101:783 (Feb. 1998). |
Kremer, J. et al., “Clinical, Laboratory, Radiographic, and Histopathologic Features of Methotrexate-Associated Lung Injury In Patients with Rheumatoid Arthritis”, Arthritis & Rheumatism, 40:1829 (Oct. 1997). |
Opal, S.M. et al., “Interleukin-10: Potential Benefits and Possible Risks in Clinical Infectious Diseases”, Clinical Infectious Diseases 27:1497, XP000915244 (1998). |
Moritani M. et al., “Prevention of Adoptively Transferred Diabetes in Nonbese Diabetic Mice with IL-10-Transduced Islet-specific Th 1 Lymphocytes” J. Clin. Invest., 98:1851, XP-002152055 (1996). |
Weinblatt, M. et al., “rHUIL-10 (TENOVIL) plus Methotrexate (MTX) in active rheumatoid arthritis (RA): A phase I/II Study”, Arthritis & Rheumatism 42:S170, XP000979189 (1999). |
International Search Report for International Application No. PCT/US 00/20304 dated Jan. 30, 2001, from European Patent Office. |